Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Change in Acquisitions & Divestments (2017 - 2025)

Aclaris Therapeutics has reported Change in Acquisitions & Divestments over the past 9 years, most recently at $15.0 million for Q4 2025.

  • Quarterly results put Change in Acquisitions & Divestments at $15.0 million for Q4 2025, down 14.35% from a year ago — trailing twelve months through Dec 2025 was $89.0 million (up 3.36% YoY), and the annual figure for FY2025 was $89.0 million, up 3.36%.
  • Change in Acquisitions & Divestments for Q4 2025 was $15.0 million at Aclaris Therapeutics, down from $19.1 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for ACRS hit a ceiling of $70.6 million in Q2 2023 and a floor of $8.0 million in Q4 2023.
  • Median Change in Acquisitions & Divestments over the past 5 years was $25.7 million (2021), compared with a mean of $30.2 million.
  • Biggest five-year swings in Change in Acquisitions & Divestments: skyrocketed 376.81% in 2021 and later tumbled 83.64% in 2023.
  • Aclaris Therapeutics' Change in Acquisitions & Divestments stood at $26.3 million in 2021, then surged by 85.56% to $48.8 million in 2022, then tumbled by 83.64% to $8.0 million in 2023, then soared by 119.17% to $17.5 million in 2024, then fell by 14.35% to $15.0 million in 2025.
  • The last three reported values for Change in Acquisitions & Divestments were $15.0 million (Q4 2025), $19.1 million (Q3 2025), and $25.0 million (Q2 2025) per Business Quant data.